Company intelligence / Profile preview

Exactech

Gainesville, Florida, United Statesexac.co.uk ↗

Ownership: Public · EXAC
Employees: ~900
Development stage: Commercial

Overview

Exactech’s products are commercially available and widely used globally for joint replacement surgeries. The company has a broad portfolio of FDA-cleared and CE-marked devices for hip, knee, shoulder, foot, and ankle arthroplasty. Their Active Intelligence platform provides data-driven tools to support surgeons in improving patient outcomes.

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Financials

Market cap: $0
Total revenue: $61.4M
Enterprise value: $2.3M

Beyond the preview

Go deeper on Exactech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exactech.

Explore the full profile